GUANFACINE

GUANFACINE was reported 8070 times

GUANFACINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GAMING DISORDER 4 0.2105
1 POOR SCHOOL ATTENDANCE 4 0.1600
2 DISRUPTIVE MOOD DYSREGULATION DISORDER 7 0.0946
3 MACULAR DETACHMENT 18 0.0744
4 SELECTIVE MUTISM 6 0.0714
5 INTERMITTENT EXPLOSIVE DISORDER 8 0.0684
6 OPPOSITIONAL DEFIANT DISORDER 24 0.0608
7 ANTICHOLINERGIC EFFECT 4 0.0533
8 DEFIANT BEHAVIOUR 16 0.0519
9 ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED 4 0.0426
10 FORCED EXPIRATORY VOLUME ABNORMAL 6 0.0414
11 FOETAL ALCOHOL SYNDROME 4 0.0400
12 WITHDRAWAL HYPERTENSION 8 0.0396
13 ATRIOVENTRICULAR DISSOCIATION 7 0.0327
14 RESTLESS LEG AUGMENTATION SYNDROME 5 0.0323
15 CHOROIDAL EFFUSION 22 0.0274
16 SELF-DESTRUCTIVE BEHAVIOUR 23 0.0264
17 NEGATIVISM 19 0.0250
18 DISTURBANCE IN SOCIAL BEHAVIOUR 59 0.0250
19 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 4 0.0223
20 EDUCATIONAL PROBLEM 37 0.0222
21 GRANDIOSITY 8 0.0219
22 IMPULSIVE BEHAVIOUR 79 0.0210
23 TIC 114 0.0209
24 HYPERTENSIVE URGENCY 11 0.0199
25 BODY MASS INDEX DECREASED 9 0.0194
26 CONDUCT DISORDER 4 0.0194
27 VENTRICULAR DYSKINESIA 4 0.0192
28 ZINC DEFICIENCY 4 0.0186
29 ELECTROCARDIOGRAM T WAVE PEAKED 7 0.0174
30 ACTIVATION SYNDROME 6 0.0173
31 TRICHOTILLOMANIA 10 0.0171
32 DRUG-GENETIC INTERACTION 6 0.0168
33 ELECTROCARDIOGRAM QT SHORTENED 5 0.0165
34 NEPHROGENIC DIABETES INSIPIDUS 19 0.0165
35 OROMANDIBULAR DYSTONIA 12 0.0165
36 DISTRACTIBILITY 17 0.0147
37 GROWTH FAILURE 5 0.0145
38 ORTHOSTATIC INTOLERANCE 10 0.0139
39 DERMATILLOMANIA 8 0.0134
40 CHANGE IN SUSTAINED ATTENTION 4 0.0133
41 SEROUS RETINAL DETACHMENT 11 0.0131
42 DRUG DOSE TITRATION NOT PERFORMED 24 0.0131
43 SINUS ARRHYTHMIA 17 0.0130
44 CARDIOVASCULAR SYMPTOM 5 0.0129
45 ANION GAP 8 0.0126
46 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 5 0.0119
47 BRUGADA SYNDROME 12 0.0116
48 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 5 0.0112
49 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 15 0.0111
50 PERIODIC LIMB MOVEMENT DISORDER 4 0.0109
51 CHOROIDAL DETACHMENT 6 0.0108
52 BEHAVIOUR DISORDER 57 0.0105
53 HEAD BANGING 6 0.0105
54 BRADYPNOEA 28 0.0104
55 ATTENTION DEFICIT HYPERACTIVITY DISORDER 42 0.0100
56 MANUFACTURING MATERIALS ISSUE 4 0.0099
57 AUTISM SPECTRUM DISORDER 53 0.0096
58 SINUS ARREST 15 0.0096
59 ENURESIS 37 0.0092
60 UPPER AIRWAY OBSTRUCTION 8 0.0090
61 GRIMACING 7 0.0090
62 DISTRIBUTIVE SHOCK 20 0.0088
63 EXCESSIVE EYE BLINKING 13 0.0088
64 PSYCHOMOTOR HYPERACTIVITY 145 0.0087
65 WOLFF-PARKINSON-WHITE SYNDROME 4 0.0085
66 PATIENT UNCOOPERATIVE 4 0.0084
67 HYPERTENSIVE ENCEPHALOPATHY 5 0.0084
68 SUBRETINAL FLUID 9 0.0082
69 VERBAL ABUSE 4 0.0082
70 AGGRESSION 399 0.0080
71 AUTISM 8 0.0079
72 ADHESIVE TAPE USE 3 0.0078
73 POSTURING 4 0.0077
74 ELECTROCARDIOGRAM T WAVE ABNORMAL 12 0.0077
75 HYPERTENSIVE EMERGENCY 9 0.0076
76 SOCIAL ANXIETY DISORDER 5 0.0076
77 ANTICHOLINERGIC SYNDROME 12 0.0075
78 HALLUCINATION, TACTILE 5 0.0075
79 SINUS BRADYCARDIA 72 0.0074
80 STEREOTYPY 7 0.0074
81 HOMICIDAL IDEATION 30 0.0074
82 STARVATION 6 0.0072
83 PROTRUSION TONGUE 4 0.0069
84 VASOPLEGIA SYNDROME 11 0.0067
85 ELECTROCARDIOGRAM QT PROLONGED 235 0.0065
86 PHYSICAL ASSAULT 13 0.0062
87 CHANGE IN SEIZURE PRESENTATION 4 0.0062
88 ABNORMAL BEHAVIOUR 229 0.0058
89 PHARYNGEAL PARAESTHESIA 9 0.0057
90 HOSTILITY 14 0.0055
91 SELECTIVE EATING DISORDER 5 0.0055
92 SEDATION COMPLICATION 14 0.0055
93 SELF-INJURIOUS IDEATION 23 0.0055
94 DRUG EFFECT VARIABLE 6 0.0053
95 INSULIN RESISTANCE 11 0.0053
96 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 37 0.0052
97 BRADYCARDIA 272 0.0051
98 TRANSCRIPTION MEDICATION ERROR 8 0.0051
99 INTRUSIVE THOUGHTS 6 0.0051
100 DRUG EFFECT INCREASED 16 0.0051
101 CARDIAC ANEURYSM 5 0.0050
102 STARING 12 0.0050
103 INTENTIONAL SELF-INJURY 100 0.0049
104 PRIAPISM 17 0.0049
105 LOGORRHOEA 17 0.0048
106 JUDGEMENT IMPAIRED 7 0.0048
107 GROWTH RETARDATION 14 0.0048
108 HYPOPROTEINAEMIA 9 0.0047
109 ANGER 155 0.0046
110 CATATONIA 24 0.0046
111 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 4 0.0045
112 AUTONOMIC NERVOUS SYSTEM IMBALANCE 13 0.0044
113 INHIBITORY DRUG INTERACTION 7 0.0044
114 HYPERAMMONAEMIA 22 0.0044
115 SCREAMING 28 0.0044
116 ABULIA 4 0.0043
117 INTENTIONAL OVERDOSE 275 0.0043
118 MAST CELL ACTIVATION SYNDROME 6 0.0043
119 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 29 0.0043
120 HYPORESPONSIVE TO STIMULI 5 0.0043
121 AFFECTIVE DISORDER 33 0.0042
122 SLEEP TALKING 7 0.0041
123 OBSESSIVE-COMPULSIVE DISORDER 33 0.0041
124 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 25 0.0041
125 AFFECT LABILITY 39 0.0040
126 DRUG TOLERANCE 20 0.0039
127 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 20 0.0039
128 SEDATION 102 0.0039
129 IMMUNE THROMBOCYTOPENIC PURPURA 11 0.0039
130 IMPULSE-CONTROL DISORDER 8 0.0039
131 DISINHIBITION 6 0.0037
132 PRODUCT ADMINISTRATION INTERRUPTED 29 0.0037
133 DYSPHEMIA 16 0.0036
134 BIPOLAR I DISORDER 8 0.0036
135 STRESS CARDIOMYOPATHY 21 0.0036
136 EOSINOPHILIC OESOPHAGITIS 10 0.0036
137 SELF INJURIOUS BEHAVIOUR 11 0.0036
138 SLEEP TERROR 15 0.0036
139 DARK CIRCLES UNDER EYES 5 0.0034
140 PSYCHOTIC SYMPTOM 7 0.0034
141 SUICIDAL BEHAVIOUR 14 0.0034
142 SLEEP DEFICIT 7 0.0033
143 FORCED EXPIRATORY VOLUME DECREASED 9 0.0032
144 SEROTONIN SYNDROME 61 0.0032
145 INAPPROPRIATE AFFECT 5 0.0032
146 PRODUCT SUBSTITUTION ISSUE 178 0.0031
147 BICYTOPENIA 6 0.0031
148 NEPHROGENIC ANAEMIA 14 0.0030
149 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 10 0.0030
150 TROPONIN I INCREASED 5 0.0030
151 DIZZINESS POSTURAL 29 0.0030
152 SUICIDAL IDEATION 271 0.0030
153 IRRITABILITY 178 0.0030
154 GAZE PALSY 5 0.0029
155 CARBON DIOXIDE INCREASED 4 0.0029
156 LONG QT SYNDROME 7 0.0029
157 LEARNING DISORDER 7 0.0029
158 SOCIAL PROBLEM 12 0.0029
159 WRONG DOSE 7 0.0029
160 DROOLING 20 0.0029
161 TACHYPHRENIA 10 0.0029
162 DYSTONIA 56 0.0029
163 HEART RATE ABNORMAL 16 0.0029
164 INFUSION SITE DISCHARGE 5 0.0028
165 FRUSTRATION TOLERANCE DECREASED 23 0.0028
166 TORTICOLLIS 6 0.0028
167 TONIC CONVULSION 4 0.0028
168 AGITATION 207 0.0028
169 MANIA 46 0.0028
170 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 15 0.0028
171 NEGATIVE THOUGHTS 8 0.0027
172 DISTURBANCE IN ATTENTION 147 0.0027
173 DRUG TITRATION ERROR 7 0.0027
174 DRUG PRESCRIBING ERROR 52 0.0027
175 SKIN STRIAE 4 0.0027
176 PERSONALITY DISORDER 7 0.0027
177 INITIAL INSOMNIA 27 0.0026
178 FLAT AFFECT 6 0.0026
179 VIOLENCE-RELATED SYMPTOM 4 0.0026
180 BLOOD CREATININE DECREASED 8 0.0026
181 DEPRESSIVE SYMPTOM 9 0.0026
182 INFUSION SITE PRURITUS 8 0.0025
183 EMOTIONAL DISORDER 78 0.0025
184 INABILITY TO AFFORD MEDICATION 25 0.0025
185 INCREASED APPETITE 48 0.0025
186 HYPERPHAGIA 10 0.0025
187 BIPOLAR DISORDER 27 0.0025
188 SELF ESTEEM DECREASED 6 0.0025
189 ORTHOSTATIC HYPOTENSION 43 0.0025
190 HALLUCINATION, AUDITORY 39 0.0025
191 NEUROLEPTIC MALIGNANT SYNDROME 29 0.0024
192 THERAPY CHANGE 24 0.0024
193 CARDIAC DYSFUNCTION 9 0.0024
194 DRUG LEVEL ABOVE THERAPEUTIC 11 0.0024
195 PULSELESS ELECTRICAL ACTIVITY 10 0.0024
196 CONTRAINDICATED PRODUCT PRESCRIBED 4 0.0024
197 SOMNOLENCE 479 0.0024
198 HALLUCINATIONS, MIXED 10 0.0024
199 SUSPECTED SUICIDE 11 0.0023
200 THERAPEUTIC PRODUCT INEFFECTIVE 9 0.0023
201 GYNAECOMASTIA 72 0.0023
202 MEDICATION RESIDUE PRESENT 11 0.0023
203 CEREBRAL DISORDER 17 0.0023
204 SOMNAMBULISM 15 0.0023
205 DRUG WITHDRAWAL CONVULSIONS 4 0.0022
206 PRE-EXISTING CONDITION IMPROVED 14 0.0022
207 DISSOCIATION 17 0.0022
208 THERAPEUTIC RESPONSE CHANGED 14 0.0022
209 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 21 0.0022
210 AGORAPHOBIA 3 0.0022
211 HYPOMANIA 8 0.0022
212 WRONG TECHNIQUE IN DRUG USAGE PROCESS 79 0.0022
213 REACTION TO EXCIPIENT 5 0.0022
214 HYPERTRICHOSIS 4 0.0022
215 LISTLESS 7 0.0021
216 NARCOLEPSY 4 0.0021
217 PRODUCT AVAILABILITY ISSUE 48 0.0021
218 ANXIETY DISORDER 7 0.0021
219 TEARFULNESS 9 0.0021
220 BLOOD PRESSURE DECREASED 138 0.0021
221 LETHARGY 119 0.0021
222 CONVERSION DISORDER 4 0.0021
223 HALLUCINATION, VISUAL 43 0.0020
224 SUICIDE ATTEMPT 123 0.0020
225 DRUG DELIVERY SYSTEM ISSUE 4 0.0020
226 HYPERPROLACTINAEMIA 13 0.0020
227 PERSECUTORY DELUSION 5 0.0020
228 RECALLED PRODUCT ADMINISTERED 19 0.0020
229 CRANIOCEREBRAL INJURY 6 0.0020
230 SUDDEN HEARING LOSS 4 0.0020
231 HYPOTHERMIA 20 0.0020
232 PRESCRIBED OVERDOSE 38 0.0020
233 RESPIRATORY DEPRESSION 24 0.0020
234 MOOD SWINGS 62 0.0019
235 POST-TRAUMATIC STRESS DISORDER 13 0.0019
236 BLOOD PROLACTIN INCREASED 9 0.0019
237 ABNORMAL LOSS OF WEIGHT 13 0.0019
238 MOOD ALTERED 52 0.0019
239 DEVICE MATERIAL ISSUE 4 0.0019
240 SOCIAL AVOIDANT BEHAVIOUR 11 0.0019
241 RESTLESSNESS 69 0.0019
242 APPLICATION SITE ERYTHEMA 49 0.0019
243 APPLICATION SITE SCAB 4 0.0019
244 SNORING 7 0.0018
245 ATRIOVENTRICULAR BLOCK FIRST DEGREE 8 0.0018
246 GENERALISED TONIC-CLONIC SEIZURE 30 0.0018
247 ATRIOVENTRICULAR BLOCK 14 0.0018
248 THERAPEUTIC PRODUCT EFFECT VARIABLE 7 0.0018
249 DRUG ADMINISTERED AT INAPPROPRIATE SITE 19 0.0018
250 CARDIAC FAILURE ACUTE 12 0.0018
251 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4 0.0018
252 DYSPHORIA 9 0.0018
253 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
254 PETIT MAL EPILEPSY 9 0.0018
255 SYNCOPE 176 0.0018
256 AKATHISIA 24 0.0018
257 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
258 HYPERTONIC BLADDER 5 0.0017
259 MIDDLE INSOMNIA 32 0.0017
260 DRUG ADMINISTRATION ERROR 52 0.0017
261 PSYCHOTIC DISORDER 50 0.0017
262 WITHDRAWAL SYNDROME 71 0.0017
263 PRODUCT PREPARATION ISSUE 11 0.0017
264 INFUSION SITE REACTION 5 0.0017
265 APPETITE DISORDER 11 0.0017
266 REBOUND ACID HYPERSECRETION 5 0.0017
267 BLOOD IMMUNOGLOBULIN E INCREASED 4 0.0017
268 INCORRECT DRUG ADMINISTRATION DURATION 46 0.0016
269 PARADOXICAL DRUG REACTION 6 0.0016
270 ABNORMAL WEIGHT GAIN 20 0.0016
271 ALTERED STATE OF CONSCIOUSNESS 35 0.0016
272 HYPERACUSIS 6 0.0016
273 APPLICATION SITE IRRITATION 20 0.0016
274 DEVICE MECHANICAL ISSUE 22 0.0016
275 PRESYNCOPE 39 0.0016
276 RESPIRATORY RATE DECREASED 5 0.0016
277 ELECTROENCEPHALOGRAM ABNORMAL 5 0.0016
278 DEPRESSED LEVEL OF CONSCIOUSNESS 62 0.0016
279 MYDRIASIS 20 0.0016
280 TRISMUS 8 0.0015
281 PRODUCT QUALITY ISSUE 210 0.0015
282 PALLOR 42 0.0015
283 CRYING 56 0.0015
284 THERAPY PARTIAL RESPONDER 24 0.0015
285 RESPIRATORY ACIDOSIS 6 0.0015
286 INFUSION SITE HAEMORRHAGE 5 0.0015
287 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5 0.0015
288 THIRST 27 0.0015
289 HYPOTENSION 303 0.0015
290 PERSONALITY CHANGE 14 0.0015
291 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
292 AREFLEXIA 4 0.0015
293 PRODUCT RESIDUE PRESENT 8 0.0015
294 BRUXISM 8 0.0015
295 DELUSION 23 0.0015
296 PHARYNGITIS STREPTOCOCCAL 16 0.0015
297 PRODUCT DISPENSING ERROR 32 0.0015
298 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 9 0.0015
299 PERIPHERAL COLDNESS 20 0.0015
300 HEART RATE DECREASED 51 0.0015
301 AKINESIA 3 0.0014
302 TOXICITY TO VARIOUS AGENTS 244 0.0014
303 SEIZURE 167 0.0014
304 DRUG SCREEN FALSE POSITIVE 4 0.0014
305 CYSTIC FIBROSIS 8 0.0014
306 MUSCLE TWITCHING 33 0.0014
307 ELECTRIC SHOCK SENSATION 4 0.0014
308 DRUG TOLERANCE DECREASED 4 0.0014
309 PRODUCT CONTAMINATION 5 0.0014
310 GALACTORRHOEA 9 0.0014
311 SALIVARY HYPERSECRETION 14 0.0014
312 PARANOIA 24 0.0014
313 PRODUCT PHYSICAL ISSUE 28 0.0014
314 HYPERVENTILATION 8 0.0014
315 INSURANCE ISSUE 21 0.0014
316 APATHY 20 0.0014
317 ACCIDENTAL OVERDOSE 50 0.0014
318 DEPRESSED MOOD 72 0.0014
319 DRUG EFFECT LESS THAN EXPECTED 20 0.0013
320 MENTAL DISORDER 58 0.0013
321 WRONG PRODUCT ADMINISTERED 9 0.0013
322 DYSARTHRIA 50 0.0013
323 HYPERSOMNIA 38 0.0013
324 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
325 OBESITY 21 0.0013
326 EYE MOVEMENT DISORDER 9 0.0013
327 TROPONIN INCREASED 10 0.0013
328 ARRHYTHMIA 62 0.0013
329 INFUSION SITE ERYTHEMA 11 0.0013
330 OVERWEIGHT 7 0.0013
331 HALLUCINATION 98 0.0013
332 POOR QUALITY DEVICE USED 13 0.0013
333 FORMICATION 9 0.0013
334 RHINOVIRUS INFECTION 5 0.0013
335 EPILEPSY 39 0.0013
336 SINUS TACHYCARDIA 18 0.0013
337 TREATMENT FAILURE 105 0.0013
338 BRAIN OEDEMA 16 0.0013
339 POLYDIPSIA 5 0.0013
340 MUSCLE RIGIDITY 15 0.0013
341 MIOSIS 10 0.0012
342 DRUG INTERACTION 193 0.0012
343 ACUTE PSYCHOSIS 3 0.0012
344 PRODUCT FORMULATION ISSUE 8 0.0012
345 NEAR DEATH EXPERIENCE 4 0.0012
346 EXPIRED DEVICE USED 4 0.0012
347 UNRESPONSIVE TO STIMULI 31 0.0012
348 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
349 TACHYCARDIA 106 0.0012
350 DECREASED INTEREST 7 0.0012
351 ENERGY INCREASED 7 0.0012
352 IMPAIRED QUALITY OF LIFE 17 0.0012
353 ABNORMAL UTERINE BLEEDING 3 0.0012
354 OBSTRUCTIVE AIRWAYS DISORDER 13 0.0012
355 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
356 CEREBRAL ISCHAEMIA 6 0.0012
357 CONCUSSION 9 0.0012
358 APNOEA 9 0.0012
359 HAIR GROWTH ABNORMAL 8 0.0012
360 MENTAL IMPAIRMENT 28 0.0012
361 REBOUND EFFECT 13 0.0011
362 NO ADVERSE EVENT 208 0.0011
363 DRUG LEVEL INCREASED 19 0.0011
364 SENSITIVITY TO WEATHER CHANGE 6 0.0011
365 THINKING ABNORMAL 21 0.0011
366 INTENTIONAL DOSE OMISSION 32 0.0011
367 PRODUCT SUPPLY ISSUE 8 0.0011
368 FRUSTRATION 4 0.0011
369 INSOMNIA 297 0.0011
370 INFUSION SITE SWELLING 7 0.0011
371 DYSKINESIA 45 0.0011
372 DRUG EFFECT DELAYED 5 0.0011
373 IMPAIRED GASTRIC EMPTYING 15 0.0011
374 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
375 PSYCHIATRIC SYMPTOM 8 0.0011
376 STREPTOCOCCAL INFECTION 6 0.0011
377 COMA 51 0.0011
378 CATHETER SITE INFECTION 4 0.0011
379 SLEEP DISORDER 74 0.0010
380 POOR QUALITY SLEEP 22 0.0010
381 DRUG EFFECT DECREASED 55 0.0010
382 BRAIN FOG 16 0.0010
383 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 72 0.0010
384 SUSPECTED COUNTERFEIT PRODUCT 4 0.0010
385 PRODUCT ADHESION ISSUE 36 0.0010
386 MYOSITIS 9 0.0010
387 ARTERIOSPASM CORONARY 4 0.0010
388 BLINDNESS UNILATERAL 14 0.0010
389 URINARY RETENTION 33 0.0010
390 EATING DISORDER 21 0.0010
391 ANXIETY 280 0.0010
392 SUBSTANCE ABUSE 8 0.0010
393 NIGHTMARE 34 0.0010
394 SLUGGISHNESS 10 0.0010
395 PRODUCT USE ISSUE 184 0.0010
396 EUPHORIC MOOD 10 0.0010
397 BLOOD CREATINE PHOSPHOKINASE INCREASED 28 0.0010
398 PANIC REACTION 7 0.0010
399 APPLICATION SITE PRURITUS 22 0.0010
400 SCOLIOSIS 6 0.0010
401 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
402 FEAR 26 0.0010
403 RASH PUSTULAR 7 0.0010
404 COMPLETED SUICIDE 80 0.0010
405 MAJOR DEPRESSION 7 0.0010
406 WEIGHT INCREASED 214 0.0010
407 CYANOSIS 15 0.0010
408 BLEPHAROSPASM 6 0.0010
409 INCONTINENCE 10 0.0009
410 URINARY INCONTINENCE 28 0.0009
411 GASTROENTERITIS VIRAL 17 0.0009
412 SEXUAL DYSFUNCTION 11 0.0009
413 ENCEPHALOPATHY 23 0.0009
414 PRODUCT DISPENSING ISSUE 4 0.0009
415 SENSORY DISTURBANCE 15 0.0009
416 ATAXIA 11 0.0009
417 PARKINSONISM 9 0.0009
418 CHAPPED LIPS 4 0.0009
419 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
420 DEVICE PHYSICAL PROPERTY ISSUE 7 0.0009
421 NONSPECIFIC REACTION 5 0.0009
422 FOOD ALLERGY 7 0.0009
423 EAR INFECTION 24 0.0009
424 DEVICE INFORMATION OUTPUT ISSUE 7 0.0009
425 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
426 LOSS OF CONSCIOUSNESS 114 0.0009
427 PRODUCT USE COMPLAINT 14 0.0009
428 STATUS EPILEPTICUS 10 0.0009
429 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
430 GRANULOCYTOPENIA 5 0.0009
431 DERMATITIS CONTACT 10 0.0009
432 CONVULSION 50 0.0009
433 EXERCISE TOLERANCE DECREASED 5 0.0009
434 GRAND MAL CONVULSION 8 0.0009
435 BLOOD URIC ACID INCREASED 5 0.0009
436 APPLICATION SITE PAIN 19 0.0009
437 HUNGER 12 0.0009
438 COGNITIVE DISORDER 40 0.0009
439 INFUSION SITE PAIN 11 0.0009
440 TARDIVE DYSKINESIA 24 0.0008
441 RETCHING 18 0.0008
442 PRODUCT ADMINISTRATION ERROR 17 0.0008
443 PULSE ABSENT 4 0.0008
444 TREATMENT NONCOMPLIANCE 46 0.0008
445 FEELING JITTERY 16 0.0008
446 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 46 0.0008
447 DECREASED ACTIVITY 9 0.0008
448 VISUAL FIELD DEFECT 6 0.0008
449 TYPE 1 DIABETES MELLITUS 5 0.0008
450 INJECTION SITE VESICLES 5 0.0008
451 LIQUID PRODUCT PHYSICAL ISSUE 6 0.0008
452 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
453 SKIN FISSURES 16 0.0008
454 DECREASED APPETITE 190 0.0008
455 RENAL CELL CARCINOMA 4 0.0008
456 OVERDOSE 176 0.0008
457 COELIAC DISEASE 8 0.0008
458 HYPERHIDROSIS 105 0.0008
459 DEVICE BREAKAGE 33 0.0008
460 PRODUCT TASTE ABNORMAL 11 0.0008
461 VENTRICULAR FIBRILLATION 9 0.0008
462 SKIN HAEMORRHAGE 12 0.0008
463 EXPIRED DRUG ADMINISTERED 4 0.0008
464 MUCOUS STOOLS 4 0.0008
465 DELIRIUM 28 0.0008
466 FLUID INTAKE REDUCED 4 0.0008
467 PANIC ATTACK 29 0.0008
468 MENTAL STATUS CHANGES 22 0.0008
469 DEPRESSION 180 0.0008
470 DIABETIC KETOACIDOSIS 19 0.0008
471 DRUG DISPENSING ERROR 12 0.0008
472 CARDIOTOXICITY 7 0.0008
473 PULMONARY OEDEMA 35 0.0008
474 INCOHERENT 5 0.0008
475 WEIGHT FLUCTUATION 8 0.0008
476 BLOOD LACTIC ACID INCREASED 4 0.0008
477 PRODUCT DISTRIBUTION ISSUE 7 0.0008
478 NYSTAGMUS 4 0.0008
479 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
480 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
481 OFF LABEL USE 643 0.0007
482 BLOOD TESTOSTERONE DECREASED 5 0.0007
483 ASPIRATION 8 0.0007
484 EXTRAPYRAMIDAL DISORDER 18 0.0007
485 DERMATITIS ATOPIC 38 0.0007
486 ACCIDENTAL EXPOSURE 3 0.0007
487 HYPERTENSIVE CRISIS 8 0.0007
488 MOVEMENT DISORDER 23 0.0007
489 CIRCULATORY COLLAPSE 12 0.0007
490 BRAIN INJURY 7 0.0007
491 CARDIOGENIC SHOCK 10 0.0007
492 THERAPEUTIC RESPONSE SHORTENED 23 0.0007
493 DIPLOPIA 18 0.0007
494 METABOLIC DISORDER 4 0.0007
495 DRUG LEVEL DECREASED 7 0.0007
496 LACTIC ACIDOSIS 22 0.0007
497 TEMPERATURE INTOLERANCE 7 0.0007
498 DRY MOUTH 55 0.0007
499 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 137 0.0007
500 FEELING DRUNK 5 0.0007
501 DEVICE LEAKAGE 29 0.0007
502 THERAPEUTIC RESPONSE UNEXPECTED 30 0.0007
503 SCRATCH 7 0.0007
504 HEAD INJURY 21 0.0007
505 THERAPY CESSATION 34 0.0007
506 CONDITION AGGRAVATED 201 0.0007
507 END STAGE RENAL DISEASE 12 0.0007
508 HYPERTENSION 138 0.0007
509 COORDINATION ABNORMAL 9 0.0006
510 SKIN LACERATION 7 0.0006
511 DRUG INEFFECTIVE 846 0.0006
512 PULMONARY HAEMORRHAGE 5 0.0006
513 POISONING 8 0.0006
514 PRODUCT PACKAGING ISSUE 6 0.0006
515 SLEEP APNOEA SYNDROME 12 0.0006
516 PARALYSIS 9 0.0006
517 HYPOPHAGIA 16 0.0006
518 GASTROINTESTINAL DISORDER 56 0.0006
519 TRANSPLANT REJECTION 5 0.0006
520 THERAPY NON-RESPONDER 28 0.0006
521 CARDIAC FLUTTER 4 0.0006
522 HEPATITIS ACUTE 4 0.0006
523 RENAL TUBULAR NECROSIS 6 0.0006
524 ECZEMA 32 0.0006
525 FEELING COLD 17 0.0006
526 PRODUCT DOSE OMISSION ISSUE 178 0.0006
527 MENSTRUAL DISORDER 5 0.0006
528 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
529 THERAPEUTIC PRODUCT EFFECT DECREASED 27 0.0006
530 PRESCRIBED UNDERDOSE 12 0.0006
531 DRUG DOSE OMISSION BY DEVICE 47 0.0006
532 PRODUCT PRESCRIBING ISSUE 13 0.0006
533 HEART RATE INCREASED 59 0.0006
534 DIZZINESS 297 0.0006
535 PRODUCT USE IN UNAPPROVED INDICATION 147 0.0006
536 FEEDING DISORDER 12 0.0006
537 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10 0.0006
538 CONSTIPATION 127 0.0006
539 DRUG DOSE OMISSION 96 0.0006
540 POOR VENOUS ACCESS 6 0.0006
541 DRUG INTOLERANCE 56 0.0006
542 VENTRICULAR EXTRASYSTOLES 6 0.0006
543 HYSTERECTOMY 5 0.0006
544 DISCOMFORT 35 0.0006
545 PALPITATIONS 67 0.0006
546 VIRAL INFECTION 19 0.0006
547 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
548 RESPIRATORY RATE INCREASED 5 0.0006
549 LOSS OF LIBIDO 5 0.0006
550 DEVELOPMENTAL DELAY 5 0.0006
551 PRODUCT PRESCRIBING ERROR 13 0.0005
552 ORAL DISORDER 4 0.0005
553 VENTRICULAR TACHYCARDIA 9 0.0005
554 BLOOD PRESSURE INCREASED 83 0.0005
555 SENSITIVE SKIN 4 0.0005
556 ARTHROPOD BITE 4 0.0005
557 SPEECH DISORDER 28 0.0005
558 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
559 DISORIENTATION 21 0.0005
560 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
561 THERAPEUTIC RESPONSE DECREASED 32 0.0005
562 POISONING DELIBERATE 5 0.0005
563 DERMATITIS 11 0.0005
564 ACIDOSIS 4 0.0005
565 CARDIAC ARREST 43 0.0005
566 INFLUENZA 58 0.0005
567 FEELING ABNORMAL 124 0.0005
568 COLD SWEAT 9 0.0005
569 TORSADE DE POINTES 4 0.0005
570 APPLICATION SITE RASH 7 0.0005
571 BODY TEMPERATURE DECREASED 5 0.0005
572 ERECTILE DYSFUNCTION 13 0.0005
573 PRODUCT DOSE OMISSION 33 0.0005
574 ILLNESS 52 0.0005
575 LOW BIRTH WEIGHT BABY 4 0.0005
576 MYOCLONUS 6 0.0005
577 ADVERSE DRUG REACTION 45 0.0005
578 HYPOTONIA 5 0.0005
579 TREMOR 83 0.0005
580 VOMITING 235 0.0005
581 LEUKOCYTOSIS 9 0.0005
582 ABDOMINAL PAIN UPPER 102 0.0005
583 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
584 SCHIZOPHRENIA 6 0.0005
585 NASAL CONGESTION 29 0.0005
586 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 35 0.0005
587 DRY THROAT 5 0.0005
588 INTENTIONAL PRODUCT USE ISSUE 43 0.0005
589 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
590 RIB FRACTURE 10 0.0005
591 STAPHYLOCOCCAL INFECTION 16 0.0005
592 NERVOUS SYSTEM DISORDER 15 0.0005
593 PHOTOPHOBIA 9 0.0005
594 SHOCK 11 0.0005
595 BLOOD UREA INCREASED 8 0.0005
596 ADVERSE EVENT 44 0.0005
597 MIGRAINE 45 0.0005
598 METABOLIC ACIDOSIS 15 0.0005
599 VITAMIN D DECREASED 4 0.0005
600 FATIGUE 364 0.0005
601 PRODUCT CONTAINER ISSUE 4 0.0005
602 PSEUDOMONAS INFECTION 4 0.0005
603 HEREDITARY ANGIOEDEMA 5 0.0005
604 HOSPITALISATION 71 0.0005
605 CHOKING 9 0.0005
606 HEADACHE 289 0.0005
607 DEVICE USE ERROR 16 0.0005
608 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
609 INTENTIONAL PRODUCT MISUSE 40 0.0005
610 DEVICE ADHESION ISSUE 7 0.0005
611 DISABILITY 9 0.0005
612 PRODUCT COMMUNICATION ISSUE 4 0.0005
613 DEHYDRATION 60 0.0004
614 WRONG DRUG ADMINISTERED 4 0.0004
615 MALNUTRITION 5 0.0004
616 DYSSTASIA 13 0.0004
617 ANAL INCONTINENCE 4 0.0004
618 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
619 OROPHARYNGEAL DISCOMFORT 4 0.0004
620 EPISTAXIS 33 0.0004
621 FEELING HOT 27 0.0004
622 WEIGHT DECREASED 122 0.0004
623 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 8 0.0004
624 UNEVALUABLE EVENT 33 0.0004
625 INCREASED TENDENCY TO BRUISE 4 0.0004
626 MEDICATION ERROR 24 0.0004
627 SINUSITIS 44 0.0004
628 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 20 0.0004
629 MOUTH ULCERATION 9 0.0004
630 HYPOXIA 15 0.0004
631 SEASONAL ALLERGY 6 0.0004
632 DEVICE ISSUE 38 0.0004
633 AMNESIA 27 0.0004
634 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
635 FLUSHING 42 0.0004
636 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
637 NO THERAPEUTIC RESPONSE 5 0.0004
638 PAIN OF SKIN 11 0.0004
639 CHRONIC KIDNEY DISEASE 31 0.0004
640 POLLAKIURIA 17 0.0004
641 INCORRECT DOSE ADMINISTERED 93 0.0004
642 LIGAMENT SPRAIN 4 0.0004
643 NIGHT SWEATS 13 0.0004
644 ILEUS 5 0.0004
645 UPPER LIMB FRACTURE 8 0.0004
646 NEUROTOXICITY 7 0.0004
647 RESPIRATORY ARREST 11 0.0004
648 EMOTIONAL DISTRESS 48 0.0004
649 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
650 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
651 CHEST PAIN 73 0.0004
652 MOTOR DYSFUNCTION 4 0.0004
653 ASTHMA 44 0.0004
654 ANAPHYLACTIC SHOCK 10 0.0004
655 RESTLESS LEGS SYNDROME 7 0.0004
656 DEAFNESS 10 0.0004
657 ANHEDONIA 10 0.0004
658 JOINT DISLOCATION 4 0.0004
659 ADVERSE REACTION 5 0.0004
660 BLOOD PRESSURE FLUCTUATION 9 0.0004
661 BODY HEIGHT DECREASED 4 0.0004
662 ABDOMINAL PAIN 87 0.0004
663 IRRITABLE BOWEL SYNDROME 8 0.0004
664 SINUS CONGESTION 5 0.0004
665 TINNITUS 17 0.0004
666 PRURITUS GENERALISED 8 0.0004
667 DYSPHAGIA 35 0.0004
668 OROPHARYNGEAL PAIN 34 0.0004
669 INJECTION SITE URTICARIA 9 0.0004
670 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 66 0.0004
671 EYE DISORDER 12 0.0004
672 LOWER LIMB FRACTURE 7 0.0004
673 GASTROINTESTINAL PAIN 4 0.0004
674 FOOT DEFORMITY 4 0.0004
675 LIP SWELLING 12 0.0004
676 GAIT INABILITY 12 0.0004
677 DRUG EFFECT INCOMPLETE 13 0.0004
678 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
679 PARAESTHESIA 56 0.0004
680 EYE PAIN 20 0.0004
681 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
682 IMPAIRED DRIVING ABILITY 4 0.0004
683 SCAB 4 0.0004
684 SCAR 6 0.0004
685 CHOLECYSTECTOMY 4 0.0003
686 EYE SWELLING 13 0.0003
687 NEPHROLITHIASIS 16 0.0003
688 ABDOMINAL DISCOMFORT 58 0.0003
689 FALL 115 0.0003
690 NERVOUSNESS 18 0.0003
691 HYPOKINESIA 5 0.0003
692 HEAD DISCOMFORT 6 0.0003
693 NAUSEA 268 0.0003
694 RENAL INJURY 10 0.0003
695 RHABDOMYOLYSIS 14 0.0003
696 HYPERLIPIDAEMIA 4 0.0003
697 HYPERSENSITIVITY 62 0.0003
698 NASOPHARYNGITIS 61 0.0003
699 FUNGAL INFECTION 11 0.0003
700 ECONOMIC PROBLEM 5 0.0003
701 ACNE 25 0.0003
702 HYPERGLYCAEMIA 12 0.0003
703 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
704 UNDERDOSE 24 0.0003
705 DYSURIA 12 0.0003
706 CARDIOMEGALY 4 0.0003
707 HYPOKALAEMIA 15 0.0003
708 SPINAL OPERATION 4 0.0003
709 BRONCHITIS 24 0.0003
710 GENERALISED OEDEMA 4 0.0003
711 SWELLING FACE 21 0.0003
712 URTICARIA 54 0.0003
713 THERAPY INTERRUPTED 23 0.0003
714 EXTRA DOSE ADMINISTERED 13 0.0003
715 BLOOD SODIUM DECREASED 6 0.0003
716 RASH 138 0.0003
717 FOOT FRACTURE 6 0.0003
718 PNEUMOTHORAX 5 0.0003
719 RASH MACULAR 11 0.0003
720 ANGINA PECTORIS 9 0.0003
721 RASH ERYTHEMATOUS 15 0.0003
722 RASH PRURITIC 17 0.0003
723 COVID-19 55 0.0003
724 VISION BLURRED 43 0.0003
725 VERTIGO 19 0.0003
726 DRUG RESISTANCE 8 0.0003
727 ROAD TRAFFIC ACCIDENT 13 0.0003
728 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
729 RHINORRHOEA 20 0.0003
730 HYPOGLYCAEMIA 15 0.0003
731 MUSCLE TIGHTNESS 5 0.0003
732 EAR PAIN 6 0.0003
733 SURGERY 18 0.0003
734 INCORRECT DOSE ADMINISTERED BY DEVICE 8 0.0003
735 SKIN DISCOLOURATION 14 0.0003
736 PULMONARY CONGESTION 4 0.0003
737 SARS-COV-2 TEST POSITIVE 4 0.0003
738 BLOOD CHOLESTEROL INCREASED 14 0.0003
739 DRY SKIN 40 0.0003
740 PREGNANCY 6 0.0003
741 GASTROINTESTINAL HAEMORRHAGE 25 0.0003
742 TYPE 2 DIABETES MELLITUS 10 0.0003
743 ABDOMINAL DISTENSION 31 0.0003
744 OCULAR HYPERAEMIA 14 0.0003
745 FLUID RETENTION 15 0.0003
746 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
747 DEVICE DELIVERY SYSTEM ISSUE 8 0.0003
748 MUSCULOSKELETAL DISCOMFORT 5 0.0003
749 DEVICE DEFECTIVE 5 0.0003
750 NEURALGIA 7 0.0003
751 MALAISE 126 0.0003
752 HAEMOPTYSIS 8 0.0003
753 CARPAL TUNNEL SYNDROME 4 0.0003
754 AMENORRHOEA 5 0.0003
755 DEVICE OCCLUSION 4 0.0003
756 ABASIA 7 0.0003
757 PAIN IN JAW 8 0.0003
758 JOINT INJURY 6 0.0003
759 IMPAIRED WORK ABILITY 6 0.0003
760 PNEUMONIA ASPIRATION 7 0.0003
761 COUGH 78 0.0003
762 PARAESTHESIA ORAL 4 0.0003
763 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
764 PRODUCT COMPLAINT 7 0.0003
765 INJECTION SITE REACTION 19 0.0003
766 CHOLELITHIASIS 9 0.0003
767 RESPIRATORY FAILURE 20 0.0003
768 IMPAIRED HEALING 9 0.0003
769 CHEST DISCOMFORT 28 0.0003
770 INJECTION SITE MASS 10 0.0003
771 DRUG WITHDRAWAL SYNDROME NEONATAL 4 0.0003
772 CONTUSION 26 0.0003
773 STEVENS-JOHNSON SYNDROME 6 0.0003
774 CONJUNCTIVITIS 5 0.0003
775 IMMUNODEFICIENCY 4 0.0003
776 BACTERIAL INFECTION 5 0.0003
777 HEPATIC FUNCTION ABNORMAL 10 0.0003
778 EYE PRURITUS 9 0.0003
779 RASH PAPULAR 6 0.0003
780 RESPIRATORY DISORDER 8 0.0003
781 MUSCLE SPASMS 49 0.0003
782 PANCREATITIS ACUTE 6 0.0003
783 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
784 CONFUSIONAL STATE 43 0.0003
785 HYPOAESTHESIA ORAL 4 0.0003
786 APHASIA 8 0.0003
787 PANCREATITIS 14 0.0003
788 RENAL FAILURE 35 0.0003
789 INJECTION SITE SWELLING 20 0.0003
790 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
791 PERIPHERAL SWELLING 40 0.0003
792 GLAUCOMA 5 0.0003
793 LIMB DISCOMFORT 8 0.0003
794 OEDEMA 14 0.0003
795 LIMB INJURY 7 0.0003
796 RENAL DISORDER 12 0.0003
797 ORAL HERPES 5 0.0003
798 PRURITUS 98 0.0003
799 SICKLE CELL ANAEMIA WITH CRISIS 4 0.0003
800 ABNORMAL DREAMS 7 0.0003
801 ASTHENIA 95 0.0003
802 SINUS DISORDER 5 0.0003
803 CATARACT 15 0.0003
804 INFLAMMATION 13 0.0003
805 BLOOD PRESSURE ABNORMAL 5 0.0003
806 PYREXIA 87 0.0003
807 OXYGEN SATURATION DECREASED 14 0.0002
808 LOCALISED INFECTION 6 0.0002
809 ADRENAL INSUFFICIENCY 3 0.0002
810 FLATULENCE 14 0.0002
811 BLOOD POTASSIUM INCREASED 4 0.0002
812 BACK DISORDER 4 0.0002
813 PRODUCT PREPARATION ERROR 5 0.0002
814 PHOTOSENSITIVITY REACTION 4 0.0002
815 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
816 EXPIRED PRODUCT ADMINISTERED 8 0.0002
817 DRY EYE 12 0.0002
818 GAIT DISTURBANCE 46 0.0002
819 CARDIO-RESPIRATORY ARREST 10 0.0002
820 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
821 FACE OEDEMA 4 0.0002
822 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
823 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
824 CARDIAC FAILURE 19 0.0002
825 HEPATIC ENZYME INCREASED 16 0.0002
826 GENERAL PHYSICAL HEALTH DETERIORATION 27 0.0002
827 MEMORY IMPAIRMENT 32 0.0002
828 BLOOD POTASSIUM DECREASED 7 0.0002
829 RASH GENERALISED 6 0.0002
830 BLISTER 13 0.0002
831 INJECTION SITE PAIN 71 0.0002
832 OEDEMA PERIPHERAL 28 0.0002
833 ACUTE KIDNEY INJURY 35 0.0002
834 PNEUMONIA 74 0.0002
835 DRUG WITHDRAWAL SYNDROME 20 0.0002
836 DEVICE DIFFICULT TO USE 15 0.0002
837 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
838 EYE IRRITATION 13 0.0002
839 SKIN EXFOLIATION 19 0.0002
840 TRANSAMINASES INCREASED 5 0.0002
841 SWOLLEN TONGUE 7 0.0002
842 MENSTRUATION IRREGULAR 6 0.0002
843 ORAL PAIN 5 0.0002
844 SNEEZING 5 0.0002
845 GOUT 4 0.0002
846 DYSPHONIA 13 0.0002
847 TOOTHACHE 4 0.0002
848 PAIN IN EXTREMITY 65 0.0002
849 HYPOAESTHESIA 33 0.0002
850 MUSCULAR WEAKNESS 25 0.0002
851 CYSTITIS 7 0.0002
852 HYPOTHYROIDISM 7 0.0002
853 DIARRHOEA 141 0.0002
854 HAEMATOCHEZIA 12 0.0002
855 SWELLING 20 0.0002
856 ACCIDENTAL EXPOSURE TO PRODUCT 22 0.0002
857 DYSPEPSIA 21 0.0002
858 HOT FLUSH 16 0.0002
859 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
860 PRODUCTIVE COUGH 10 0.0002
861 HERPES ZOSTER 12 0.0002
862 BALANCE DISORDER 18 0.0002
863 ACUTE RESPIRATORY FAILURE 4 0.0002
864 LIVER FUNCTION TEST ABNORMAL 6 0.0002
865 NEEDLE ISSUE 6 0.0002
866 URINARY TRACT INFECTION 35 0.0002
867 CHILLS 24 0.0002
868 CEREBRAL INFARCTION 5 0.0002
869 KIDNEY INFECTION 4 0.0002
870 LIVER DISORDER 9 0.0002
871 DYSGEUSIA 15 0.0002
872 HAEMATOCRIT DECREASED 4 0.0002
873 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
874 COMPLICATION OF DEVICE INSERTION 4 0.0002
875 INFECTION 29 0.0002
876 ANAPHYLACTIC REACTION 11 0.0002
877 LYMPHADENOPATHY 7 0.0002
878 ILL-DEFINED DISORDER 12 0.0002
879 HAEMATEMESIS 5 0.0002
880 NECK PAIN 11 0.0002
881 BODY TEMPERATURE INCREASED 4 0.0002
882 ERYTHEMA 40 0.0002
883 VISUAL IMPAIRMENT 24 0.0002
884 SKIN ULCER 5 0.0002
885 DRUG DEPENDENCE 31 0.0002
886 RESPIRATORY TRACT INFECTION 5 0.0002
887 BLOOD GLUCOSE INCREASED 36 0.0002
888 DYSPNOEA 108 0.0002
889 RENAL IMPAIRMENT 16 0.0002
890 GASTRITIS 5 0.0002
891 DISEASE RECURRENCE 9 0.0002
892 INTESTINAL OBSTRUCTION 7 0.0002
893 DIABETES MELLITUS 14 0.0002
894 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
895 INFLUENZA LIKE ILLNESS 15 0.0002
896 STOMATITIS 11 0.0002
897 RESPIRATORY DISTRESS 5 0.0002
898 PROCEDURAL PAIN 5 0.0002
899 CHROMATURIA 4 0.0002
900 HEART RATE IRREGULAR 4 0.0002
901 BACK PAIN 41 0.0002
902 BLINDNESS 7 0.0002
903 INJURY 12 0.0002
904 CEREBRAL HAEMORRHAGE 6 0.0002
905 MOBILITY DECREASED 12 0.0002
906 BLOOD GLUCOSE DECREASED 8 0.0002
907 HEPATIC FAILURE 5 0.0002
908 ARTHRITIS 13 0.0002
909 FIBROMYALGIA 4 0.0002
910 PLEURAL EFFUSION 10 0.0002
911 RECTAL HAEMORRHAGE 7 0.0002
912 HYPOACUSIS 7 0.0002
913 NEUTROPENIA 22 0.0002
914 SEPTIC SHOCK 7 0.0002
915 AGEUSIA 4 0.0002
916 CARDIAC DISORDER 15 0.0002
917 MUSCULOSKELETAL STIFFNESS 14 0.0002
918 ANGIOEDEMA 7 0.0002
919 NEUROPATHY PERIPHERAL 15 0.0002
920 PAIN 96 0.0002
921 HAEMATOMA 4 0.0002
922 EXPOSURE VIA SKIN CONTACT 4 0.0002
923 INJECTION SITE ERYTHEMA 19 0.0002
924 SKIN IRRITATION 7 0.0002
925 SKIN DISORDER 5 0.0001
926 JAUNDICE 4 0.0001
927 FREQUENT BOWEL MOVEMENTS 4 0.0001
928 BLOOD BILIRUBIN INCREASED 4 0.0001
929 THROAT TIGHTNESS 4 0.0001
930 PSORIASIS 19 0.0001
931 ARTHRALGIA 60 0.0001
932 DRUG ABUSE 12 0.0001
933 ARTHROPATHY 8 0.0001
934 LUNG DISORDER 7 0.0001
935 DEVICE MALFUNCTION 10 0.0001
936 RENAL FAILURE ACUTE 6 0.0001
937 DEVICE DISLOCATION 6 0.0001
938 DYSPNOEA EXERTIONAL 5 0.0001
939 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
940 INJECTION SITE RASH 4 0.0001
941 MYALGIA 22 0.0001
942 EXPOSURE DURING PREGNANCY 8 0.0001
943 PULMONARY EMBOLISM 12 0.0001
944 PRODUCT STORAGE ERROR 11 0.0001
945 SEPSIS 14 0.0001
946 ABORTION SPONTANEOUS 5 0.0001
947 PSORIATIC ARTHROPATHY 5 0.0001
948 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
949 ABDOMINAL PAIN LOWER 3 0.0001
950 WHEEZING 7 0.0001
951 OSTEOARTHRITIS 5 0.0001
952 ALOPECIA 23 0.0001
953 GASTRIC DISORDER 4 0.0001
954 BURNING SENSATION 8 0.0001
955 HYPERKALAEMIA 4 0.0001
956 CARDIAC FAILURE CONGESTIVE 9 0.0001
957 COLITIS ULCERATIVE 5 0.0001
958 SKIN BURNING SENSATION 8 0.0001
959 THROAT IRRITATION 5 0.0001
960 DEVICE EXPULSION 7 0.0001
961 INJECTION SITE PRURITUS 7 0.0001
962 CEREBROVASCULAR ACCIDENT 17 0.0001
963 INJECTION SITE HAEMORRHAGE 8 0.0001
964 CELLULITIS 5 0.0001
965 NEUTROPHIL COUNT DECREASED 4 0.0001
966 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
967 HAEMORRHAGE 10 0.0001
968 MUSCULOSKELETAL PAIN 5 0.0001
969 DISEASE PROGRESSION 11 0.0001
970 ATRIAL FIBRILLATION 9 0.0001
971 DEEP VEIN THROMBOSIS 6 0.0001
972 VAGINAL HAEMORRHAGE 4 0.0001
973 INFUSION RELATED REACTION 6 0.0001
974 PANCYTOPENIA 5 0.0001
975 ANAEMIA 17 0.0001
976 HYPONATRAEMIA 5 0.0001
977 PLATELET COUNT DECREASED 9 0.0001
978 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
979 INJECTION SITE BRUISING 6 0.0001
980 NEOPLASM MALIGNANT 5 0.0001
981 THROMBOSIS 6 0.0001
982 JOINT SWELLING 9 0.0001
983 MYOCARDIAL INFARCTION 12 0.0001
984 HAEMOGLOBIN DECREASED 7 0.0001
985 DEATH 55 0.0001
986 FEBRILE NEUTROPENIA 4 0.0001
987 THROMBOCYTOPENIA 6 0.0001
988 RHEUMATOID ARTHRITIS 5 0.0000